Table 1 Excerpt of the internal guideline: recommendations on treatment of bronchial obstruction
Inhaler device | Children <12 years | Children >12 years | Interval (minimum) | |
|---|---|---|---|---|
Regular dosage regimen | Nebulization (1 drop = 0,25 mg) | 1-2 drops per life year, min. single dose 3 drops (recommendation by the local Pediatric Pneumology Section), max. single dose 8 drops; 3-4 times/day | 5-10 drops, 3-5 times/day, max. daily dose 50 drops | 4 hours |
Metered dose inhaler (MDI) (1 puff = 100 μg) | 1 puff 3-4 times/day; as needed up to 6 puffs/day | 1-2 puffs 3-4 times/day; as needed up to 12 puffs/day | 3 hours | |
High dosage regimen | • Recommendation in cases of severe obstruction or insufficient inhalation technique according to the local Pediatric Pneumology Section: 2 puffs 6 times/day (MDI) | |||
• Note: inform family/carer on off-label use; higher doses need to be discussed with a senior physician | ||||
General remarks | • Children <5 years: prefer MDI with spacer (use facemask if necessary) | |||
• Increased single dose/frequency possible as needed for symptoms in individual cases (off-label) | ||||
• Good response to salbutamol/recovery from symptoms: reduce interval between inhalations to 3 hours (MDI) or 4 hours (nebulization) | ||||
• No oral β2-agonists in acute situations | ||||
Disclaimer | • The recommendations cover only routine care situations, in individual cases therapy has to be adjusted to the individual needs. | |||
• The therapy decision is the sole responsibility of the prescribing physician. | ||||
• This information does not replace the approved summary of product characteristics. | ||||